Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors at 2 institutions in 2 countries.
Charlotte BauerINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Université Côte d'Azur, 660 Route des Lucioles, Sophia-Antipolis, 06560 Valbonne, France.
Eric DuplanINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Université Côte d'Azur, 660 Route des Lucioles, Sophia-Antipolis, 06560 Valbonne, France.ORCID 0000-0002-1348-1507
Peter Saint-George-HyslopCenter for Research in Neurodegenerative Diseases, Department of Medicine, Toronto Western Hospital Research Institute, University Health Network, University of Toronto, Toronto, ON M5G 1L7, Canada.
Frédéric CheclerINSERM, CNRS, IPMC, Team Labeled "Laboratory of Excellence (LABEX) Distalz", Université Côte d'Azur, 660 Route des Lucioles, Sophia-Antipolis, 06560 Valbonne, France.ORCID 0000-0003-2098-1750
Centre National de la Recherche Scientifique · FRUniversity Health Network · CA
Funding
DisTALZ ANR : ANR-11-LABX-0009
6 · The paper itself
Abstract
The
Indexed as
Alzheimer DiseaseAmyloid beta-Protein PrecursorAmyloid beta-PeptidesAnimalsCricetinaeCricetulusHEK293 CellsHumansLDL-Receptor Related ProteinsMembrane Transport ProteinsMutationAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAPP protein, humanLDL-Receptor Related ProteinsMembrane Transport ProteinsSORL1 protein, humanAPPAβ peptidescellular localizationC-terminal fragmentsdegradationmutationsneprilysinproteasomesecretasesSORL1transient and stable expressions
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Potentially Pathogenic · full record | OpenQuestion